Letter to the Editor: MicroRNA levels and anti-VEGF therapy in glioblastoma.
Institute for Basic Health Sciences, Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, Brazil; and.|Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Advanced Center of Neurology and Neurosurgery (CEANNE)-Brazil, Porto Alegre, Brazil.
Rafael
R
Roesler
Institute for Basic Health Sciences, Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, Brazil; and.|Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Advanced Center of Neurology and Neurosurgery (CEANNE)-Brazil, Porto Alegre, Brazil.
Gustavo R
GR
Isolan
D000068258:Bevacizumab; D001932:Brain Neoplasms; D005909:Glioblastoma; D006801:Humans; D035683:MicroRNAs; D042461:Vascular Endothelial Growth Factor A
D035683:MicroRNAs; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab